CDSCO monthly lab alert
CDSCO NSQ alert, April 2025: 196 drug batches flagged
By Blacklisted editorial team· Published 20 May 2025· Updated 3 Nov 2026· Source: CDSCO NSQ portal
In its April 2025 alert, the Central Drugs Standard Control Organisation listed 196 drug batches that failed quality tests, 74 at central laboratories and 122 at state drug-testing laboratories, from 124 manufacturers across 121 products. The most common failure was dissolution, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1, Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ), Sodium Chloride Injection IP 0.9 %w/v.
196
Batches flagged
74 / 122
Central / state labs
Dissolution
Top reason
124
Manufacturers
Batches per month, last 12 alerts
May 2024Apr 2025 · 196
Full list of NSQ batches, April 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Z&D Syrup (Zinc Gluconate Oral Solution 20mg) | Batch XSZE24005Mfg Aug 2024 · Exp Jan 2026 | Hema Laboratories Pvt LtdUttarakhand | Sample does not conform to Label Claim with respect to content of Elemental Zinc in Zinc GluconateLabelling | DTL MaduraiState lab |
| Winocin 500 (Paracetamol tablets IP 500 mg) | Batch JT-2405719Mfg May 2024 · Exp Oct 2026 | Jineka Healthcare Pvt. LtdUttarakhand | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | SDTL Agartala, TripuraState lab |
| WORMKILL-PLUS (Albendazole & Ivermectin Oral Suspension) | Batch SRVL-24003Mfg Jun 2024 · Exp May 2026 | SPAS RemediesHimachal Pradesh | Assay for Albendazole and IvermectinAssay | State Lab KarnatakaState lab |
| Teneligliptin & Metformin Hydrochloride (Sustained Release) Tablets IP (Teglisure-M 500) | Batch AOT244-00BMfg Mar 2024 · Exp Feb 2026 | Astonea Labs Pvt. LtdHaryana | Assay/content of TeneligliptinAssay | CDL KolkataCDSCO lab |
| Telmisartan Tab IP 40 mg | Batch D0004/25-26Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | The sample does not conform to IP standards with respect to descriptive part for tabletsOther | DTL ThiruvananthapuramState lab |
| Telmisartan I.P. 40 mg, Amlodipine Besylate I.P. 5 mg Tablets | Batch ST 211Mfg Apr 2024 · Exp Mar 2026 | Soham Healhcare INCGujarat | "Dissolution" (Telmisartan and Amlodipine) and "Assay/ content of Telmisartan and Amlodipine"Assay | CDTL MumbaiCDSCO lab |
| Telmisartan & Hydrochlorothiazide Tablets IP (Telmijack-H) | Batch T-20560Mfg Mar 2024 · Exp Feb 2026 | Jackson Laboratories Pvt. Ltd | "Related substances and Assay of Hydrochlorothiazi de"Assay | CDTL MumbaiCDSCO lab |
| Telmisartan & Amlodipine Tablets IP (XTEL-AM) | Batch BBT240427AMfg May 2024 · Exp Apr 2026 | Biomax Biotechnics (P) Ltd. 261Haryana | The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of AmlodipineDissolution | DTL BaddiState lab |
| Telmisartan & Amlodipine Tablets IP | Batch UGT24G06AMfg Oct 2024 · Exp Sep 2026 | Unigrow PharmaceuticalsHimachal Pradesh | It fails the tests for ?Assay? of Amlodipine and ?Dissolution? as specified in the Laboratory Protocol as per IPAssay | DTL ThiruvananthapuramState lab |
| Telivi-H 40 (Telmisartan & Hydrochorothiazide Tablets IP | Batch BLT23348Mfg Jun 2023 · Exp May 2025 | BRIT Lifescience a GMP Certified Company) Sainwala kaula WataHimachal Pradesh | 1. The content of Telmisartan and Hydrochlorothiazide in the sample is less (i.e. 83.13% and 79.44%of the labelled amount respectively) than I.P. limits. 2. The sample does not comply with I.P. Requirements for "Dissolution Test" for Telemisartan and Hydrochlorothiazide.Dissolution | CDTL MumbaiCDSCO lab |
| Tab Telmisartan IP 40 mg | Batch GTM18Mfg Jun 2024 · Exp May 2026 | Super Formulation Pvt Ltd | It fails the test ?Dissolution? as per IP, specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Synclov-625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | Batch MICTAB-2120Mfg Jan 2025 · Exp Jun 2026 | Micro FormulationsHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to the content of Clavulanic Acid in Potassium Clavulanate Diluted Dissolution for Clavulanic Acid and toDissolution | DTL ChennaiState lab |
| Sulphamethoxazole and Trimethoprim Tablets IP | Batch MT386Mfg Oct 2023 · Exp Sep 2026 | Mayasha LifesciencesHimachal Pradesh | Dissolution of Sulphamethoxazol eDissolution | RDTL ChandigarhCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | Batch 23051901Mfg May 2023 · Exp Apr 2026 | Reyoung Pharmaceutical Co. Ltd | "Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | Batch 23051806Mfg May 2023 · Exp Apr 2026 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | Batch 23051903Mfg May 2023 · Exp Apr 2026 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP. | Batch 23051902Mfg May 2023 · Exp Apr 2026 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sulbactam Sodium Sterile I.P./USP | Batch 23051904Mfg May 2023 · Exp Apr 2026 | Reyoung Pharmaceutical Co. Ltd | Identification and Assay/Content of Sulbactam SodiumAssay | RDTL GuwahatiCDSCO lab |
| Sucrapolis-O Suspension | Batch CSDL24368Mfg Oct 2024 · Exp Sep 2026 | CSD LifesciencesHimachal Pradesh | sample does not conform to label claim with respect to the content of OxetacaineLabelling | DTL ChennaiState lab |
| Sucralfate & Oxetacaine Suspension (Rabeflux Suspension) | Batch RBLS-02501Mfg Jan 2025 · Exp Dec 2026 | Tidal Laboratories Pvt. Ltd | Identification, Assay of Sucralfate and Assay of OxetacaineAssay | CDL KolkataCDSCO lab |
| Spoorthi Aloegramflour Soap | Batch 6Mfg Jun 2024 · Exp May 2027 | Spoorthi Herbals No.:299Karnataka | Test for Matter insoluble in Alcohol onlyOther | State Lab KarnatakaState lab |
| Softuss-D (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup) | Batch DL2501013BMfg Jan 2025 · Exp Dec 2026 | Indorama Health Care Pvt LtdHaryana | Sample does not conform to IP specification for label claim with respect to the content of Phenylephrine HydrochlorideLabelling | DTL ChennaiState lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4983Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4979Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4987Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4984Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4985Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4982Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4978Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP 0.9 %w/v | Batch LV4988Mfg Nov 2024 · Exp Oct 2026 | Captab BiotecHimachal Pradesh | Particulate matter, Bacterial endotoxins and SterilitySterility | RDTL ChandigarhCDSCO lab |
| Sodium Chloride Injection IP (0.9% W/v) NS | Batch 4HB01401Mfg May 2024 · Exp Apr 2027 | Aishwarya LifesciencesHimachal Pradesh | Test for SterilitySterility | State Lab KarnatakaState lab |
| Ronnin 500mg Tablets (Azithromycin Tablets IP 500mg) | Batch PPTC082Mfg Nov 2023 · Exp Oct 2026 | Pratima Pharmaceuticals G.No. 56/3Maharashtra | The sample does not give IP identification test for the presence of Azithromycin. The sample is declared as spurious vide section 17-B(d) of the Drugs and Cosmetics Act, 1940 and Rules, 1945 thereunderIdentification | State Lab MaharashtraState lab |
| Rifampicin, Isoniazid and Ethmbutol Hydrochloride Tablets IP | Batch TR-820008Mfg Jul 2024 · Exp Jun 2026 | Centurion Remedies Pvt. LtdGujarat | Assay of RifampicinAssay | CDL KolkataCDSCO lab |
| Restomol 650 (Paracetamol Tablets IP 650 mg) | Batch K1224079Mfg Dec 2024 · Exp Nov 2027 | Kaushik Therapeutics (P) LtdTamil Nadu | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Rabeprazole Sodium Injection IP | Batch MD23H19Mfg Aug 2023 · Exp Jul 2025 | Martin & Brown Bio-Sciences Pvt. LtdHimachal Pradesh | pH, Particulate matter, Clarity of Solution, Assay of Rabeprazole Sodium and DescriptionAssay | CDL KolkataCDSCO lab |
| Proxtl 100 DT | Batch PXT123F02Mfg Mar 2023 · Exp May 2025 | INDU Drugs Pvt Ltd.5-5- 35/278Telangana | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | Batch PSWAB66Mfg Jun 2024 · Exp Nov 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab |
| Povigin (Povidone Iodine Ointment USP 5%w/w) | Batch PZ-2414Mfg Sep 2024 · Exp Aug 2026 | GP Glister Pharmaceutical | Sample does not conform to USP specification for Povidone- Iodine Ointment with respect to the content of Available Iodine in Povidone- IodineOther | DTL ChennaiState lab |
| Polergy (Levocetizine Tablets IP 5mg) | Batch 43037Mfg Jul 2023 · Exp Jun 2025 | M/.s Ronak Life care Pvt Ltd | All tablets received for analysis shows light brown coloured spots all over the surface of the tablets when observed in normal daylight with unaided eyes.Description | CDTL MumbaiCDSCO lab |
| Pioglitazone Hydrochloride Tablets (GLITO 15) | Batch D40292Mfg May 2024 · Exp Apr 2027 | Medley Pharmaceuticals LtdDaman & Diu | "Dissolution"Dissolution | CDTL MumbaiCDSCO lab |
| Phytorab-DSR Capsules | Batch GC 41481Mfg Jun 2023 · Exp May 2025 | J.M. LaboratoriesHimachal Pradesh | The content of rabeprazole sodium in the sample is less (i.e. 55.00% of the labelled amount) than the permissible limitsLabelling | CDTL MumbaiCDSCO lab |
| Petben (Benzoyl peroxide shampoo 2.5%) | Batch 678585Mfg Mar 2024 · Exp Feb 2026 | Hidustan Antibitics LtdHimachal Pradesh | Sample does not conform to lebel claim with respect to description of shampooDescription | DTL MaduraiState lab |
| Parasev 500 Tablets(Paracetamol Tablets IP 500mg) | Batch CHT23725Mfg Mar 2024 · Exp Feb 2026 | Cureza Healthcare Pvt Ltd. A.B Road | The tablets does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets.Description | State Lab MaharashtraState lab |
| Paracetamol, Phenylephrine HCL & Cetrizine HCL Suspension | Batch OKOL-009Mfg Jul 2024 · Exp Jun 2026 | Laborate Pharmaceuticals India Ltd | The sample does not conform to claim as per Patent and Proprietary in respect of the assay of Phenylephrine Hydrochloride.Assay | DTL BaddiState lab |
| Paracetamol Tablets IP 650 mg | Batch PCT24034Mfg Feb 2024 · Exp Jan 2026 | Vivek Pharmachem (India) LtdRajasthan | Test for Dissolution? and ?DescriptionDissolution | State Lab KarnatakaState lab |
| Paracetamol Tablets IP 500 mg | Batch PAK-517Mfg May 2023 · Exp Apr 2026 | Healer's Lab Unit IIHimachal Pradesh | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tablets IP (Pacel-650) | Batch RPTC-182Mfg Jan 2025 · Exp Dec 2027 | Chennai Oscar Bio Pharmaceuticals Pvt. LtdTamil Nadu | Does not comply with respect to test for Dissolution.Dissolution | State Lab PuducherryState lab |
| Paracetamol Tab IP 500 mg | Batch PAK-558Mfg Sep 2023 · Exp Aug 2026 | Healer's Lab Unit IIHimachal Pradesh | It fails the test ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tab IP 500 mg | Batch PAK-524Mfg May 2023 · Exp Apr 2026 | Healer's Lab Unit IIHimachal Pradesh | It fails the test ?Dissolution? as per IP specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Paracetamol Tab IP 500 mg | Batch D 0001/25-26Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the tests dissolution as per IP specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab |
| Pantozor Tablets (Pantoprazole Sodium Tablets IP) | Batch UTBO25AMfg Feb 2025 · Exp Jan 2027 | Haustus Biotech Pvt. Ltd | Sample does not conform to IP specification for Pantoprazole Tablets with respect to Dissolution in Buffer stageDissolution | DTL ChennaiState lab |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg. | Batch MT240578Mfg Aug 2024 · Exp Jul 2026 | Mancare Laboratories Pvt. LtdUttarakhand | Dissolution in Buffer StageDissolution | CDL KolkataCDSCO lab |
| Pantonis-40 (Pantoprazole Sodium Gastro Resistant Tab IP) | Batch JMT-2407371Mfg Jul 2024 · Exp Jun 2026 | JMM LaboratoriesHimachal Pradesh | It fails the test ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25019Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 29.69 mg per bolus (74.225%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25018Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Oxfendazole found to be 883.42 mg per bolus (88.342%) against labelled claim of 1000 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25038Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | 1. Description. 2. The Content of Ivermectin found to be 34.73 mg per bolus (86.825%) against labelled claim of 40 mg per bolus.Description | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25025Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 28.57 mg per bolus (71.425%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25034Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 34.91 mg per bolus (87.275%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25033Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 26.66 mg per bolus (66.65%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25032Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 30.19 mg per bolus (75.475%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25031Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | 1. The content of Ivermectin found to be 32.52 mg per bolus (81.30%) against labelled claim of 40 mg per bolus.2. The Content of Oxfendazole found to be 880.01 mg per bolus (88.001%) against labelled claim of 1000 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25037Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | 1. The content of Oxfendazole found to be mg per bolus. 2. The Content of Ivermectin found to be 28.220 mg per bolus (70.55%) 877.69 mg per bolus (87.769%) against labelled claim of 1000Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25041Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.19 mg per bolus (82.975%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25035Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 25.17 mg per bolus (62.925%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25036Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 28.66 mg per bolus (71.65%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25024Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.069 mg per bolus (82.672%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25029Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.29 mg per bolus (83.225%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25028Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be labelled claim of 40 mg per bolus. 31.82 mg per bolus (79.55%) againstLabelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25027Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 31.68 mg per bolus (79.20%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25026Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 33.055 mg per bolus (82.637%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | Batch AGWT25030Mfg Jan 2025 · Exp Dec 2026 | Argon Remedies Pvt. LtdUttarakhand | The content of Ivermectin found to be 31.66 mg per bolus (79.15%) against labelled claim of 40 mg per bolus.Labelling | State Drugs Laboratory, PunjabState lab |
| Oxcarbazepine Tablets IP 300 mg (OXCARBAJAJ 300) | Batch OXB02I24Mfg Sep 2024 · Exp Aug 2026 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | DissolutionDissolution | CDL KolkataCDSCO lab |
| Opivas 10 tablets | Batch 23C-T465Mfg Jun 2023 · Exp May 2025 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Opirin-75 Tablets (Aspirin Tablets IP 75mg) | Batch 23G-T1526Mfg Oct 2023 · Exp Sep 2025 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply for description as, almost all the tablets are brittle in nature with rough surface.Description | State Lab MaharashtraState lab |
| Opirin-75 Tablets (Aspirin Tablets IP 75mg) | Batch 23K-T2727Mfg Feb 2024 · Exp Jan 2026 | Orison Pharma International KhariHimachal Pradesh | The sample does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets.Description | State Lab MaharashtraState lab |
| Ondansetron Tablets IP 4 mg | Batch ONTB-06Mfg Sep 2024 · Exp Aug 2026 | Nestor Pharmaceuticals LimitedHaryana | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Ondansetron Oral Solution I.P. 2mg/5ml | Batch ONES-1004Mfg Sep 2024 · Exp Aug 2026 | Wings Biotech LLPHimachal Pradesh | Related SusbtancesOther | CDL KolkataCDSCO lab |
| Ondansentron Tablets IP 4mg | Batch PS39AB06Mfg Jun 2023 · Exp May 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | The sample does not comply with IP requirements for Dissolution testDissolution | CDTL MumbaiCDSCO lab |
| Omeprazole Capsules IP 20mg | Batch HCN423FMfg Jun 2024 · Exp May 2026 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to IP specification with respect to Uniformity of weightUniformity of weight/content | DTL MaduraiState lab |
| Ofloxacin & Ornidazole Tablets IP (200 mg +500 mg) (Floxo OZ) | Batch TAH-231704Mfg Sep 2023 · Exp Aug 2025 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | DescriptionDescription | State Lab KarnatakaState lab |
| Nitrobi-CR 2.6(Nitroglycerin Controlled Release Tablets 2.6mg) | Batch JT-2312229Mfg Dec 2023 · Exp Nov 2025 | Jeneka Healthcaere Pvt LtdUttarakhand | Sample does not conform to Label Claim with respect to the content of Nitroglycerine in DilutedLabelling | DTL MaduraiState lab |
| Nimesulide & Paracetamol Tablets (Somu Gold) | Batch TTX0093Mfg Jan 2024 · Exp Dec 2026 | Pro-pharma Care Pvt. LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Nimesulide & Paracetamol Bolus (Vet.) (Nip-UP Bolus) | Batch NPB-23221Mfg Feb 2024 · Exp Jan 2026 | Akme BiotecUttarakhand | Disintegration TestDisintegration | State Lab KarnatakaState lab |
| Nicocred-10 (Nicorandil Tablets 10 mg) | Batch SGT- 241195Mfg Aug 2024 · Exp Jul 2026 | SB Life Sciences Pvt LtdHimachal Pradesh | It fails the tests ?Dissolution? and ?Assay? as per IP, specified in the laboratory protocolAssay | DTL ThiruvananthapuramState lab |
| Neem tulsi face wash | Batch APN612Mfg Aug 2024 · Exp Aug 2026 | Orgello Herbal CareHimachal Pradesh | The sample does not comply with IS 14648: 2011 (Second Revision) Reaffirmed 2021 Requirements for Microbiological Examination test for Neem Tulsi Face washOther | CDTL MumbaiCDSCO lab |
| Nebivolol Tablets IP | Batch KMNB 24002Mfg Oct 2024 · Exp Sep 2026 | Ravian Life Sciences Pvt. LtdUttarakhand | It fails the test for ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab |
| Mupropet (Mupirocin Ointment IP 2%w/w) | Batch DG2436Mfg Jul 2024 · Exp Dec 2025 | Arius Formulations Pvt Ltd | Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of MupirocinOther | DTL ChennaiState lab |
| Moxivin-CV 625 (Amoxycillin and Potassium Calvulnate Tablets IP) | Batch VMIT2404Mfg Oct 2024 · Exp Sep 2026 | Vertex Pharma ChemicalsPuducherry | The Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Identification of Potassium Clavulanate, Uniformity of weight and content of Amoxycillin in Amoxycillin Trihydrate and Clavulanic Acid in Potassium Clavulanate (Deemed to be spurious).Identification | DTL MaduraiState lab |
| Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP(Moncube LC) | Batch FDMC-588Mfg Jul 2024 · Exp Jun 2026 | Firstmed Therapeutics Pvt Ltd | For the received sample Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP (Moncube LC),Presence of Spots was observed which should not be presentOther | State Lab PuducherryState lab |
| Merocet (Cetirizine Hydrochloride Syrup) | Batch 1124192Mfg Nov 2024 · Exp Oct 2026 | Kite Formulation | Sample does not conform to IP specification with respect to the PH.pH | DTL MaduraiState lab |
| Mamaearth Vitamin C daily glow light moisturising cream | Batch AM4J160Mfg Oct 2024 · Exp Oct 2026 | VA Life sciences | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ?Mercury? in finished cosmetic products as specified in the Laboratoty Protocol.Other | DTL ThiruvananthapuramState lab |
| Lulimark Creams, Luliconazole Cream 1% | Batch 92447Mfg Sep 2024 · Exp Aug 2026 | Forever LifeScience Pvt.Ltd. 74/DGujarat | Misbranded However, the designation "IP"in conjunction with the official title Luliconazole Cream was not mentioned on the label of the drug product as an indication that it purports to comply with IP standards. Hence, drug under Section 17 of the Drugs and Cosmetics Act, 1940 as it is not labeled in the prescribed manner. The drug Product Luliconazole Cream is official, i.e., it is included in the current edition of the Indian Pharamacopoeia (IP- 2022). As required under the Second Schedule of the Drugs and Cosmetics Act, 1940, the said drug Product shall mandatorily comply with the standards set out in the Indian Pharmacopoeia.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Losartan Potassium 50mg & Hydrochlorthiazide 12.5mg Tablets | Batch LMT251666Mfg Feb 2025 · Exp Jan 2027 | Life Max Cancer LaboratoriesUttarakhand | Dissolution Test: The Dissolution of Losartan Potassium and Hydrochlorthiazide does not complies within the Prescribed limit of not less than Q value i.e. 70% of labelled claim as stated in I.P 2022.Dissolution | State Drugs Laboratory, PunjabState lab |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | Batch PWBBO7Mfg Jun 2024 · Exp Nov 2025 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab |
| Levetiracetam Tablets IP 500 mg | Batch LMT241488Mfg Dec 2024 · Exp Nov 2026 | Life Max Cancer LaboratoriesUttarakhand | DissolutionDissolution | CDTL IndoreCDSCO lab |
| Levamisole & Oxyclozanide Bolus Vet. (Wormizole Bolus) | Batch EMVB-24162Mfg Oct 2024 · Exp Sep 2026 | Events CorporationHimachal Pradesh | Disintegration testDisintegration | RDTL ChandigarhCDSCO lab |
| Lelet-M Syrup (Montelukast Sodium and levocetirizine hydrochloride syrup) | Batch LLMS-063Mfg Apr 2024 · Exp Mar 2026 | IOSIS Remedies Pvt LtdHimachal Pradesh | sample does not conform to label claim with respect to content of Montelukast in Montelukast sodiumLabelling | DTL MaduraiState lab |
| Labetalol Hydrochloride Tablets IP 100 mg | Batch UGT231341Mfg Oct 2023 · Exp Sep 2025 | Unimarck Healthcare LtdUttarakhand | Test For Assay(Content) of Labetalol HydrochlorideAssay | Government of NCT of DelhiState lab |
| L-Histact-M Tablets | Batch 24DT122AMfg Jun 2026 · Exp May 2027 | Kashmik Formuation Pvt LtdGujarat | Sample does not conform to IP Specification for Levocetrizine Hydrocloride and Montelukast Tablets with respect to the contect of Levocetrizine Hydrochloride and Montelukast in Montelukast in Montelukast sodium.Other | DTL MaduraiState lab |
| Koplyco Syrup | Batch TL-6337Mfg Jun 2023 · Exp May 2023 | Ticoma Pharmacia E-17 Industrial Focal Point DebrabassiPunjab | 1. Content of vitamin B1 in the sample is less (i.e. 71.10% of the labelled amount) than the permissible limits. 2. Content of the Vitamin B2 in the sample is less (i.e. 72.74%) of the labelled amount) than the permissible limits.Labelling | CDTL MumbaiCDSCO lab |
| Kivoral Forte(Trypsin and Chymotrypsin Tablets) | Batch SB-4242Mfg Jul 2023 · Exp Jun 2025 | Sano-Cito Thereapeutics IncHimachal Pradesh | The enzymatic activity of trypsin chymotrypsin in the sample is less (i.e. 40.52%) of the labelled amount) than the permissible limits.Labelling | CDTL MumbaiCDSCO lab |
| Ketoconazole Tablets I.P. 200mg | Batch GT301737Mfg Mar 2024 · Exp Feb 2026 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | Description onlyDescription | State Lab KarnatakaState lab |
| Kelan Soap(Ketoconazole Meidcated Soap) | Batch 8091Mfg Oct 2026 · Exp Sep 2026 | Vimson DermaGujarat | sample does not conform to label claim with respect to the content of KetoconazoleLabelling | DTL MaduraiState lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 24RS15Mfg Dec 2024 · Exp Nov 2026 | SAI Parenterals LimitedTelangana | pH and AlkalinitypH | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 100mg/5ml | Batch 24RS03Mfg Jan 2024 · Exp Dec 2025 | SAI Parenterals LimitedTelangana | pHpH | CDL KolkataCDSCO lab |
| Iron Sucrose Injection USP 100 mg/5ml | Batch 24RS06Mfg Feb 2024 · Exp Jan 2026 | SAI Parenterals LimitedTelangana | pH and AlkalinitypH | CDL KolkataCDSCO lab |
| Infusion Set (BMD) | Batch BIV-020Mfg Aug 2024 · Exp Jul 2027 | Bhgwati Medicare DevicesGujarat | Test for SterilitySterility | State Lab KarnatakaState lab |
| Ibuprofen Tablets IP 400mg | Batch TF240782Mfg Jun 2024 · Exp Aug 2026 | Orchid Medlife Pvt. LtdHimachal Pradesh | Sample does not conform to claim as per I.P. 2022 w.r.t. Dissolution of Ibuprofen.Dissolution | DTL BaddiState lab |
| ITRADEL-200k | Batch SD6005CMfg Jun 2023 · Exp May 2025 | Sigma Softgel & FormulationHimachal Pradesh | The sample does not comply with IP requirements for Dissolution testDissolution | CDTL MumbaiCDSCO lab |
| Griseofulvin Tablets IP(GRISOVIK-250) | Batch 8563Mfg May 2024 · Exp Apr 2026 | Vikram Laboratories (P) Ltd | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform with respect to the test for Description.Description | State Lab PuducherryState lab |
| Glypro 1 (Glimepiride Tablets IP) 1mg | Batch FGYO-1626Mfg Dec 2024 · Exp Nov 2026 | Firstmed Therapeutics Pvt Ltd | Sample does not conform to IP specification for Glimepiride Tablets with respect to the content of GlimepirideOther | DTL MaduraiState lab |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | Batch QL0606Mfg Jun 2024 · Exp May 2026 | Quest Laboratories Pvt. Ltd | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 14 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 14x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, out of these14 � 200ml bottles, 11x200ml bottles contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension and 3x200ml bottle contain orange coloured suspension with white cakes with some cakes floating & on the top of suspension. Remaining 4x200ml bottle contains white suspension without cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab |
| Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | Batch QL0602Mfg Jun 2024 · Exp May 2026 | Quest Laboratories Pvt. Ltd | All observations are done in Normal day light conditions with unaided eyes.18 �200 ml intact brown coloured plastic bottles received for analysis. Out of these18 �200 ml bottles, in 5 �200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 5x200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, all 5�200ml bottles, contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension out of remaining 13x200ml bottle 12�200ml bottle contains white suspension without cake and mixes uniformly after shaking and 1�200ml bottles contains orange coloured suspension without any cake and mix uniformly after shakingDescription | CDTL MumbaiCDSCO lab |
| Glimepiride Tablets I.P. 1 mg | Batch 12801124Mfg Aug 2024 · Exp Jul 2026 | Karnataka Antibiotics & Pharmaceuticals LtdKarnataka | "Related substances"Related substances | CDTL MumbaiCDSCO lab |
| Glimepiride Tablets (Glimilive ? 4) | Batch MDP-649Mfg Sep 2024 · Exp Aug 2026 | Medinok Healthcare Pvt. LtdPuducherry | Misbranded (1) For the received sample Glimepiride Tablets (Glimilive ? 4), The label is mentioned as ?Approved colour used? but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules,1945 was not mentioned. (2) The sample received is labelled as Glimepiride Tablets (Glimilive ? 4), however Glimepiride Tablets is an official IP monograph (2022) hence should be labelled as Glimepiride Tablets IPMisbranded | State Lab PuducherryState lab |
| Glimepiride 1 mg & Metformin HCl 500mg (Sustained Release) Tablets IP | Batch SPT40298Mfg Sep 2024 · Exp Aug 2026 | Surge Pharmaceuticals Pvt. LtdMaharashtra | Test for Dissolution? and ?Assay for GlimeperideAssay | State Lab KarnatakaState lab |
| Gentamicin Injection IP (Gentatore Injection 80 mg/2ml) | Batch IGMG418Mfg Jul 2024 · Exp Jun 2026 | Regain LaboratoriesHaryana | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Gentamicin Injection I.P- 2ml | Batch 24BUH83Mfg Aug 2024 · Exp Jul 2026 | SVP Life SciencesUttarakhand | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab |
| Gentamicin Injection I.P- 2ml | Batch YGN4102Mfg Jul 2024 · Exp Jun 2026 | Yeluri Formulations Pvt LtdTelangana | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab |
| Gentamicin Inj. IP | Batch D0003/25-26Mfg ? · Exp ? | Kerala Medical Services Corporation LtdKerala | It fails the test particulate matter and descriptive part for injectionsParticulate matter | DTL ThiruvananthapuramState lab |
| Frusemide Tablets IP 40mg | Batch TA24283Mfg Jul 2024 · Exp Jun 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Frusemide Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Frusemide Injection IP- 2ml | Batch 24BTC63Mfg Mar 2024 · Exp Feb 2026 | SVP Life SciencesUttarakhand | Sample does not conform to requirement for sterilitySterility | King Institute ChennaiState lab |
| Fluconazole Tablets I.P. 150 mg (Megmazole- 150 Tablets) | Batch TSF-C0116Mfg Jan 2024 · Exp Dec 2025 | Spen Formulations Pvt. Ltd | Assay/Content of FluconazoleAssay | RDTL GuwahatiCDSCO lab |
| Fevimed (Paracetamol tablets IP 500 mg) | Batch 451AA05Mfg Dec 2023 · Exp Nov 2025 | Sarv PharmaceuticalsUttarakhand | The Sample does not comply for description as the tablets shows light brown coloured spots on the surface of almost all the tabletsDescription | State Lab MaharashtraState lab |
| Fevimed (Paracetamol tablets IP 500 mg) | Batch T-23204Mfg Sep 2023 · Exp Aug 2025 | Kshipra Drugs Pvt. Ltd. 40- 41/22B | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | SDTL Agartala, TripuraState lab |
| Emiral OD Tablets, Ondansetron orally disintegrating Tablets IP | Batch HT24565Mfg Jul 2024 · Exp Jun 2026 | Habitare Pharma Pvt LtdHaryana | Disintegration dose not complies as per IP.Disintegration | State Lab Drugs Control Laboratory, TelanganaState lab |
| Doxycycline Capsules IP 100 mg | Batch B240705Mfg May 2024 · Exp Apr 2026 | Bochem Healthcare Pvt. Ltd | Dissolution of DoxycyclineDissolution | RDTL ChandigarhCDSCO lab |
| Diclofenac Sodium Tablets IP | Batch THB24028ALMfg Jul 2024 · Exp Jun 2026 | Hindustan Laboratories LimitedMaharashtra | Sample does not conform to IP specification for Enteric Coated Tablets with respect to DisintegrationDisintegration | DTL ChennaiState lab |
| Defix -AZ | Batch DP-240754Mfg Sep 2024 · Exp Aug 2026 | Park Pharmaceuticals 272Haryana | The sample fails in the test for Assay content of Cefixime & Azithromycin.Assay | DTL Srinagar (J&K)State lab |
| Cresol With Soap Solution (SPARK) (LYSOL IP) | Batch J-Ly-213Mfg Mar 2025 · Exp Feb 2027 | Joe's TradersTamil Nadu | The sample received does not conform to above specification as per IP 2022 with respect to description.Description | State Lab PuducherryState lab |
| Compound Sodium Lactate Injection IP (RINGER-LACTATE SOLUTION FOR INJECTION) (RL) | Batch 1I245476Mfg Sep 2024 · Exp Aug 2027 | Aculife Healthcare Pvt. LtdGujarat | SterilitySterility | CDL KolkataCDSCO lab |
| Compound Sodium Lactate Injection I.P (Ringer Lactate Solution for injection I.P) (RL) | Batch 4D40168Mfg Oct 2024 · Exp Sep 2027 | IHL Lifesciences Pvt. Ltd | Test for SterilitySterility | State Lab KarnatakaState lab |
| Clotrimazole and Selenium Sulfide Suspension, candid tv | Batch 46230305Mfg Dec 2023 · Exp Nov 2025 | Glenmark Pharmaceuticals LtdUttarakhand | Sample does not conform to label claim with respect to identification and the content of clotrimazole (Deemed to be spurious)Identification | DTL MaduraiState lab |
| Clonazepam and Paroxetine Hydrochloride CR Tablets (Exotine CR) | Batch 17671Mfg Feb 2024 · Exp Jan 2027 | Elikem Pharmaceuticals Pvt. Ltd | Uniformity of WeightUniformity of weight/content | State Drugs Laboratory, PunjabState lab |
| Ciprofloxacin Tablets IP 250 mg (Ciprodac 250) | Batch CT24001Mfg Feb 2024 · Exp Jan 2027 | Cadila Pharmaceuticals LimitedGujarat | Dissolution" of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab |
| Ciprofloxacin Tablets IP 250 mg | Batch CITB-02Mfg Jul 2024 · Exp Jun 2026 | Nestor Pharmaceuticals LimitedHaryana | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Chlorpheniramine Maleate IP & Noscapine IP Oral Syrup (Coscopin Linctus) | Batch VTL4006Mfg Mar 2024 · Exp Feb 2026 | Biological E LimitedTelangana | Sample does not conform to Label claim with respect to the content of NoscapineLabelling | DTL MaduraiState lab |
| Cetquine 5 Tablets (Levocetirizine Dihydrochlorine Tablets IP | Batch ATX060546Mfg Jun 2023 · Exp May 2025 | Adwin PharmaHimachal Pradesh | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab |
| Ceftriaxone and Sulbactam for Injection IP (CEFRITZ S 1.5) | Batch 24DH13VMfg Aug 2024 · Exp Jul 2026 | MMG HealthcareHimachal Pradesh | Bacterial endotoxins for Sterile water for Injection.Water content | CDL KolkataCDSCO lab |
| Cefpodoxime Proxetil Tablets I.P. 200 mg (BREPOD-200) | Batch ST-25456Mfg Oct 2024 · Exp Sep 2026 | Sunvij Drugs Private LimitedGujarat | DissolutionDissolution | CDL KolkataCDSCO lab |
| Cefixime Tablets IP 400 mg | Batch HTB404GMfg Jul 2024 · Exp Jun 2026 | Himalaya Meditek Pvt. LtdUttarakhand | Sample does not conform to IP Specification for Cefixime Tablets with respect to the content of Anhydrous Cefixime in Cefixime Trihydrate.Other | DTL MaduraiState lab |
| Cefixime Oral Suspension IP Dry Syrup 30 ml | Batch CADB- 02Mfg Jun 2024 · Exp May 2026 | Nestor Pharmaceuticals LimitedHaryana | It fails the test Assay, water and descriptive part for oral liquids as per IP, as specified in the Laboratory ProtocolAssay | DTL ThiruvananthapuramState lab |
| Cefixime & Potassium Clavulanate Tablets (Alfix-CV) | Batch CT24117DMfg Aug 2024 · Exp Jan 2026 | Curehealth Pharmaceticals Pvt LtdHimachal Pradesh | Sample does not conform to label claim with respect to the content of Clavulanic Acid in Potassium Clavulanate.Labelling | DTL MaduraiState lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | Batch MO24H27Mfg Aug 2024 · Exp Jul 2026 | Martin & Brown Bio- Sciences Pvt.LtdHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | Batch MO24H21Mfg Aug 2024 · Exp Jul 2026 | Martin & Brown Bio- Sciences Pvt.LtdHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Carboxymethyl Cellulose Sodium Eye Drops IP | Batch MO24H22Mfg Aug 2024 · Exp Jul 2026 | Martin & Brown Bio- Sciences Pvt.LtdHimachal Pradesh | pH, Sterility and AssayAssay | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1292Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1286Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1298Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1301Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1302Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1303Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1304Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1305Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1306Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1289Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1294Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1299Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500) | Batch GTL1300Mfg Dec 2024 · Exp Nov 2026 | Gidsha PharmaceuticalsGujarat | Dissolution (for Calcium)Dissolution | CDL KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets IP (JKMSCL, Supply) | Batch PGT24673Mfg Sep 2024 · Exp Aug 2026 | Affy ParenteralsHimachal Pradesh | The sample does not conform to IP 2022 w.r.t Disintegration test for the sample portion receivedDisintegration | CFDL Jammu (J&K)State lab |
| Calcium & Vitamin D3 Tablets IP | Batch QT23136Mfg Nov 2024 · Exp Oct 2026 | Quest Laboratories Pvt. LtdMadhya Pradesh | Dissolution (for Calcium) and Assay of Elemental CalciumAssay | CDL KolkataCDSCO lab |
| Burmoxicla+V(Amoxycill in & Potassium Clavulanate Oral Suspension IP) | Batch ABD-187CMfg Jun 2024 · Exp Nov 2025 | Azot Life SciencesHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with Clavulanic Acid in Potassium Clavulanate respect to the content ofOther | DTL MaduraiState lab |
| Bupivacaine Hydrochloride Injection IP (Bupicain-0.5%) | Batch BPC24007Mfg Dec 2024 · Exp Oct 2026 | Themis Medicare LimitedUttarakhand | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Bisacodyl Tablets Ip 5mg | Batch TA24366Mfg Jun 2023 · Exp Apr 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Bisacodyl Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Bisacodyl Tablets IP 5mg | Batch TA24688Mfg Aug 2024 · Exp Jul 2026 | Saintlife Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Bisacodyl Tablets with respect to Dissolution (Acid medium and Buffer medium)Dissolution | DTL ChennaiState lab |
| Bisacodyl Gastro- Resistant Tablets IP (Edilax) | Batch 2418853T003Mfg Jun 2024 · Exp May 2027 | Scott-Edil Pharmacia LtdHimachal Pradesh | Does not comply with respect to test for DisintegrationDisintegration | State Lab PuducherryState lab |
| Betamethasone Valerate Ointment IP 0.1% w/w | Batch B75Mfg Aug 2024 · Exp Jul 2026 | Syndicate PharmaMadhya Pradesh | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | DTL MaduraiState lab |
| Betamethasone Valerate Cream IP | Batch E4062Mfg Feb 2024 · Exp Jan 2026 | Rhydburg Pharmaceuticals LtdUttarakhand | Sample does not conform to IP specification for Betamethasone Valerate Cream with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL MaduraiState lab |
| Atorvastatin Tablets IP 10mg | Batch AT24045Mfg Aug 2024 · Exp Jan 2026 | Eurokem Laboratories Pvt ltd | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Atorvastatin Tablets IP 10mg | Batch CT240246AMfg Jul 2024 · Exp Jun 2026 | Candour PharmaceuticalsHimachal Pradesh | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Atorvastatin Tablets IP 10mg | Batch A297Mfg Jul 2024 · Exp Jun 2026 | Rikenbik PharmaTamil Nadu | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab |
| Aspirin Gastro Resistant Tab IP 75 mg | Batch ANET1235Mfg May 2024 · Exp Apr 2026 | Unicure India LtdUttar Pradesh | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab |
| Ampicillin Sodium Injection I.P. (AMPIVEE- 500 Injection) | Batch TGDI082319 04Mfg Aug 2023 · Exp Jul 2025 | T & G MedicareHimachal Pradesh | SterillityOther | RDTL GuwahatiCDSCO lab |
| Amoxycillin and potassium clavulanate tablets IP 625 mg | Batch BT240491Mfg May 2024 · Exp Apr 2026 | Hindustan Antibiotics LtdHimachal Pradesh | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other | DTL MaduraiState lab |
| Amoxycillin and potassium clavulanate tablets IP (AUGMONT CV 625 DUP Co- amoxiclav) | Batch BT408244AMfg Aug 2024 · Exp Apr 2026 | Nikvin Healthcare (I) Pvt LtdHimachal Pradesh | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate.Other | DTL MaduraiState lab |
| Amoxycillin & Potassium Calvulanate Tablets | Batch BT406210AMfg Jun 2024 · Exp May 2026 | Nikvin Healthcare (I) Pvt LtdHimachal Pradesh | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate DilutedDissolution | DTL ChennaiState lab |
| Amitriptyline HCl & Chlordiazepoxide Tablets USP (AMTOPIC-PLUS) | Batch N2402062Mfg Feb 2024 · Exp Jan 2026 | Talent HealthcareUttarakhand | Assay for Amitriptyline onlyAssay | State Lab KarnatakaState lab |
| Amikacin Sulphate Injection I.P. 500 mg | Batch 24AM18Mfg Oct 2024 · Exp Sep 2026 | SAI Parenterals LimitedTelangana | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab |
| Ambroxol Hydrochloride Syrup 30 mg/5 ml | Batch 724559Mfg Dec 2024 · Exp Nov 2026 | Syndicate Pharma 185/BMadhya Pradesh | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ambroxol Hydrochloride Syrup | Batch 724543Mfg Nov 2024 · Exp Oct 2026 | By: Syndicate Pharma 185/BMadhya Pradesh | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab |
| Alograce Cream (Vitamin E, Honey & Aloevera Cream) | Batch A2JJX048Mfg Dec 2024 · Exp Dec 2026 | RSH Global Pvt. LtdHimachal Pradesh | The sample does not conform to IS 6608:2004 for specifications of skin cream. It fails the test for ?Heavy metals (as lead) ppm? as specified in the laboratory protocolOther | DTL ThiruvananthapuramState lab |
| Albendazole Tablets IP 400 mg | Batch T24/018AMfg Dec 2024 · Exp Nov 2026 | Samkem15-B & 10-BMadhya Pradesh | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg | Batch T24/011AMfg Dec 2024 · Exp Nov 2026 | Samkem 15-B & 10-BMadhya Pradesh | Sample Does not comply in respect of Dissolution Test as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablets IP 400 mg | Batch LMT241100Mfg Sep 2024 · Exp Aug 2026 | Life Max Cancer Laboratories | DissolutionDissolution | RDTL GuwahatiCDSCO lab |
| Albendazole Tablet IP 400 mg, | Batch T24/007AMfg Dec 2024 · Exp Nov 2026 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | Batch T24/020AMfg Dec 2024 · Exp Nov 2026 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | Batch T24/016AMfg Dec 2024 · Exp Nov 2026 | Samkem 15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | Batch T24/015AMfg Dec 2024 · Exp Nov 2025 | Samkem15-B & 10-BMadhya Pradesh | Dissolution does not comply as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | Batch C25F944019Mfg Jun 2024 · Exp May 2026 | Concept Pharmaceuticals LtdmUttarakhand | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Albendazole Tablet IP 400 mg, | Batch C25F944019Mfg Jun 2024 · Exp May 2026 | Concept Pharmaceuticals LtdmUttarakhand | Dissolution dose not complies as per IP.Dissolution | State Lab Drugs Control Laboratory, TelanganaState lab |
| Ahaglow Face Wash Gel 50 gm | Batch AHA202Mfg May 2024 · Exp Apr 2026 | Torrent Pharmaceuticals LtdMadhya Pradesh | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ?Mercury? in finished cosmetic products as specified in the Laboratory Protocol.Other | DTL ThiruvananthapuramState lab |
| Adivasi Herbal Shampoo | Batch MASH-23-101Mfg Jan 2024 · Exp Dec 2026 | Beauty Birds Cosmetics Bhatti CompoundGujarat | The sample does not comply with IS 7884:2004 specification for shampoo (Third Revision) reaffirmed 2019 requirements for microbial limitMicrobial limits | CDTL MumbaiCDSCO lab |
| Acremox-500 (Amoxycillin Trihydrate & Lactic Acid Bacillus Capsules) | Batch ABC24002Mfg Apr 2024 · Exp Mar 2026 | Alexa PharmaceuticalsHimachal Pradesh | Assay for AmoxycillinAssay | State Lab KarnatakaState lab |
| Aceclofenac With Paracetamol Tablets (S-DOL-P) | Batch MDP-018Mfg Apr 2024 · Exp Mar 2026 | Medinok Healthcare Pvt. LtdPuducherry | Misbranded The label of the container in the drug is mentioned as "Approved colour used" but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned.Misbranded | State Lab PuducherryState lab |
| Aceclofenac & Paracetamol Tablets IP | Batch GG204014Mfg Apr 2024 · Exp Mar 2026 | Innova Captab LtdHimachal Pradesh | Misbranded Product is not official in I.P as on its manufacturing date mentioned on its label i.e. April 2024.Misbranded | State Drugs Laboratory, PunjabState lab |
| Aceclofenac & Paracetamol Tablets (Aceflam P) | Batch T-2403035Mfg Mar 2024 · Exp Feb 2027 | Aagya Biotech Pvt. LtdUttarakhand | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform as per IP 2022 with respect to Description.Description | State Lab PuducherryState lab |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Sources
- Regulator
- Regulator
Changelog
- 3 Nov 2026: table generated from the CDSCO NSQ portal export (196 rows). Revised CDSCO lists are diffed on each monthly rebuild.